RYAN MOSSEY: Open Payments
NPI 1497515811 · PINEVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$974 in 53 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $887 · 2025 $974
Food & beverage: $974
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $265 |
| GENZYME CORPORATION | 5 | $122 |
| Janssen Biotech, Inc. | 5 | $97 |
| Lilly USA, LLC | 4 | $86 |
| Axsome Therapeutics, Inc. | 4 | $76 |
| Corium, LLC | 2 | $59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Novo Nordisk Inc | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
Products named: DUPIXENT, TREMFYA, VRAYLAR, SKYRIZI, Auvelity, Azstarys, QULIPTA, UBRELVY.
Industry payments across LA — which companies pay providers there.
